APO RESEARCH · REPORT
Codeine
Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.
Product & engineering
Understand the product.
Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.
Selected research
Industry Research
Codeine Industry Research Report 2026
Market perspective
Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.
Market competition is intense. Taiji, Mallinckrodt, TEVA, Johnson & Johnson, Medreich, Sanofi Aventis, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. For the major company of Codeine, Taiji and Mallinckrodt accounted for about 16% market share respectively in recent years.
Report Scope
Read the full market overview
This report quantifies the global Codeine market in terms of revenue (US$ million) and, where applicable, sales volume (M Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Codeine Market by Company
Taiji
Mallinckrodt
TEVA
Johnson & Johnson
Medreich
Sanofi Aventis
Cipla
Hikma
Pharmaceutical Associates
Novartis
Apotex
Mylan
Aristo Pharma GmbH
Lannett Company
Laboratoire Riva
Codeine Segment by Ingredient
Single-ingredient Codeine
Multi-ingredient Medications
Codeine Segment by Application
Narcotic Analgesic
Antitussive
Others
Codeine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Codeine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Codeine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Codeine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Codeine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Codeine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Codeine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by ingredient, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Single-ingredient Codeine
- Multi-ingredient Medications
Applications
- Narcotic Analgesic
- Antitussive
- Others
Companies covered
- Taiji
- Mallinckrodt
- TEVA
- Johnson & Johnson
- Medreich
- Sanofi Aventis
- Cipla
- Hikma
- Pharmaceutical Associates
- Novartis
- Apotex
- Mylan
- Aristo Pharma GmbH
- Lannett Company
- Laboratoire Riva
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Codeine Market Size (2021-2032)
- 2.2.2 Global Codeine Sales (2021-2032)
- 2.2.3 Global Codeine Market Average Price (2021-2032)
- 2.3 Codeine by Ingredient
- 2.3.1 Market Value Comparison by Ingredient (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Single-ingredient Codeine
- 2.3.3 Multi-ingredient Medications
- 2.4 Codeine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Narcotic Analgesic
- 2.4.3 Antitussive
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Codeine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Codeine Sales (M Units) of Manufacturers (2021-2026)
- 3.3 Global Codeine Revenue of Manufacturers (2021-2026)
- 3.4 Global Codeine Average Price by Manufacturers (2021-2026)
- 3.5 Global Codeine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Codeine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Codeine, Product Type & Application
- 3.8 Global Manufacturers of Codeine, Established Date
- 3.9 Global Codeine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Taiji
- 4.1.1 Taiji Company Information
- 4.1.2 Taiji Business Overview
- 4.1.3 Taiji Codeine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Taiji Codeine Product Portfolio
- 4.1.5 Taiji Recent Developments
- 4.2 Mallinckrodt
- 4.2.1 Mallinckrodt Company Information
- 4.2.2 Mallinckrodt Business Overview
- 4.2.3 Mallinckrodt Codeine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Mallinckrodt Codeine Product Portfolio
- 4.2.5 Mallinckrodt Recent Developments
- 4.3 TEVA
- 4.3.1 TEVA Company Information
- 4.3.2 TEVA Business Overview
- 4.3.3 TEVA Codeine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 TEVA Codeine Product Portfolio
- 4.3.5 TEVA Recent Developments
- 4.4 Johnson & Johnson
- 4.4.1 Johnson & Johnson Company Information
- 4.4.2 Johnson & Johnson Business Overview
- 4.4.3 Johnson & Johnson Codeine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Johnson & Johnson Codeine Product Portfolio
- 4.4.5 Johnson & Johnson Recent Developments
- 4.5 Medreich
- 4.5.1 Medreich Company Information
- 4.5.2 Medreich Business Overview
- 4.5.3 Medreich Codeine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Medreich Codeine Product Portfolio
- 4.5.5 Medreich Recent Developments
- 4.6 Sanofi Aventis
- 4.6.1 Sanofi Aventis Company Information
- 4.6.2 Sanofi Aventis Business Overview
- 4.6.3 Sanofi Aventis Codeine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Sanofi Aventis Codeine Product Portfolio
- 4.6.5 Sanofi Aventis Recent Developments
- 4.7 Cipla
- 4.7.1 Cipla Company Information
- 4.7.2 Cipla Business Overview
- 4.7.3 Cipla Codeine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Cipla Codeine Product Portfolio
- 4.7.5 Cipla Recent Developments
- 4.8 Hikma
- 4.8.1 Hikma Company Information
- 4.8.2 Hikma Business Overview
- 4.8.3 Hikma Codeine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Hikma Codeine Product Portfolio
- 4.8.5 Hikma Recent Developments
- 4.9 Pharmaceutical Associates
- 4.9.1 Pharmaceutical Associates Company Information
- 4.9.2 Pharmaceutical Associates Business Overview
- 4.9.3 Pharmaceutical Associates Codeine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Pharmaceutical Associates Codeine Product Portfolio
- 4.9.5 Pharmaceutical Associates Recent Developments
- 4.10 Novartis
- 4.10.1 Novartis Company Information
- 4.10.2 Novartis Business Overview
- 4.10.3 Novartis Codeine Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Novartis Codeine Product Portfolio
- 4.10.5 Novartis Recent Developments
- 4.11 Apotex
- 4.11.1 Apotex Company Information
- 4.11.2 Apotex Business Overview
- 4.11.3 Apotex Codeine Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Apotex Codeine Product Portfolio
- 4.11.5 Apotex Recent Developments
- 4.12 Mylan
- 4.12.1 Mylan Company Information
- 4.12.2 Mylan Business Overview
- 4.12.3 Mylan Codeine Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Mylan Codeine Product Portfolio
- 4.12.5 Mylan Recent Developments
- 4.13 Aristo Pharma GmbH
- 4.13.1 Aristo Pharma GmbH Company Information
- 4.13.2 Aristo Pharma GmbH Business Overview
- 4.13.3 Aristo Pharma GmbH Codeine Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Aristo Pharma GmbH Codeine Product Portfolio
- 4.13.5 Aristo Pharma GmbH Recent Developments
- 4.14 Lannett Company
- 4.14.1 Lannett Company Company Information
- 4.14.2 Lannett Company Business Overview
- 4.14.3 Lannett Company Codeine Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Lannett Company Codeine Product Portfolio
- 4.14.5 Lannett Company Recent Developments
- 4.15 Laboratoire Riva
- 4.15.1 Laboratoire Riva Company Information
- 4.15.2 Laboratoire Riva Business Overview
- 4.15.3 Laboratoire Riva Codeine Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Laboratoire Riva Codeine Product Portfolio
- 4.15.5 Laboratoire Riva Recent Developments
5 Global Codeine Market Scenario by Region
- 5.1 Global Codeine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Codeine Sales by Region: 2021-2032
- 5.2.1 Global Codeine Sales by Region: 2021-2026
- 5.2.2 Global Codeine Sales by Region: 2027-2032
- 5.3 Global Codeine Revenue by Region: 2021-2032
- 5.3.1 Global Codeine Revenue by Region: 2021-2026
- 5.3.2 Global Codeine Revenue by Region: 2027-2032
- 5.4 North America Codeine Market Facts & Figures by Country
- 5.4.1 North America Codeine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Codeine Sales by Country (2021-2032)
- 5.4.3 North America Codeine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Codeine Market Facts & Figures by Country
- 5.5.1 Europe Codeine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Codeine Sales by Country (2021-2032)
- 5.5.3 Europe Codeine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Codeine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Codeine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Codeine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Codeine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Codeine Market Facts & Figures by Country
- 5.7.1 South America Codeine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Codeine Sales by Country (2021-2032)
- 5.7.3 South America Codeine Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Codeine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Codeine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Codeine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Codeine Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Ingredient
- 6.1 Global Codeine Sales by Ingredient (2021-2032)
- 6.1.1 Global Codeine Sales by Ingredient (2021-2032) & (M Units)
- 6.1.2 Global Codeine Sales Market Share by Ingredient (2021-2032)
- 6.2 Global Codeine Revenue by Ingredient (2021-2032)
- 6.2.1 Global Codeine Sales by Ingredient (2021-2032) & (US$ Million)
- 6.2.2 Global Codeine Revenue Market Share by Ingredient (2021-2032)
- 6.3 Global Codeine Price by Ingredient (2021-2032)
7 Segment by Application
- 7.1 Global Codeine Sales by Application (2021-2032)
- 7.1.1 Global Codeine Sales by Application (2021-2032) & (M Units)
- 7.1.2 Global Codeine Sales Market Share by Application (2021-2032)
- 7.2 Global Codeine Revenue by Application (2021-2032)
- 7.2.1 Global Codeine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Codeine Revenue Market Share by Application (2021-2032)
- 7.3 Global Codeine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Codeine Value Chain Analysis
- 8.1.1 Codeine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Codeine Production Mode & Process
- 8.2 Codeine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Codeine Distributors
- 8.2.3 Codeine Customers
9 Global Codeine Analyzing Market Dynamics
- 9.1 Codeine Industry Trends
- 9.2 Codeine Industry Drivers
- 9.3 Codeine Industry Opportunities and Challenges
- 9.4 Codeine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst